OTC

Strength

325; 10; 6.25; 5 mg/15mL; mg/15mL; mg/15mL; mg/15mL

NDC

70677103001

Classification

Generic

Dosage Form

SOLUTION

Route

ORAL

Last Updated

12/17/2025

Approval Type

OTC MONOGRAPH DRUG

FDA Application

M012

On Market Since

6/30/2023

Pharmacological Classes

Adrenergic alpha1-Agonists
Antihistamine
Histamine Receptor Antagonists
Sigma-1 Agonist
Sigma-1 Receptor Agonists
Uncompetitive N-methyl-D-aspartate Receptor Antagonist
Uncompetitive NMDA Receptor Antagonists
alpha-1 Adrenergic Agonist

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

+0.4%

3Y

N/A

5Y

N/A

All

+0.5%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.